GW VRU tests Pfizer's new vaccine for C. diff

Press Releases
GW's David Diemert interviews for Beacon Magazine

Our director, Dr. David Diemert, recently interviewed with the Beacon Newspaper providing information on a new Pfizer study for C. diff, a bacterial infection that causes severe diarrhea. Click this link to get to the hompage: 

https://www.thebeaconnewspapers.com/

Check out the Washington Metro edition and the interview is on page 6!

 

Enrollment is still open for this study, you can find the link to the interest survey here:

https://redcap.link/gwvru-cdiff

 

vaccine

Latest News

marburg virus
Marburg outbreak is reported in Uganda, threatening to complicate Ebola response in region
Uganda has detected what appears to be a localized outbreak of Marburg virus disease, with two cases identified in a single family, according to a source familiar with the situation, although the Ugandan government had not yet publicly confirmed the outbreak at the time of publication. The…
Picture of small pox with the outer and inner core
Results show safety and immunogenicity of fractional doses of the MVA-BN mpox vaccine
This was a phase 2, randomized, open-label, non-placebo controlled trial to evaluate two partial doses o the Modified Vaccinia Ankara-Bavarian Nordin (MVA-BN) vaccine for protection against mpox.
Lassa Virus under a microscope
Safety and Immunogenicity of an rVSV Lassa Fever Vaccine Candidate
This was a phase 1, double-blind trial to examine the safety and immunogenicity of a replication-competent recombinant vesicular stomatitis virus-vectored vaccine to reduce the risk of infection and severe illness from Lassa Fever.